Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 066441/0345 | |
| Pages: | 8 |
| | Recorded: | 02/12/2024 | | |
| Attorney Dkt #: | CYTX-044-PCT/USPRV/USORD/ |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16159559
|
Filing Dt:
|
10/12/2018
|
|
Publication #:
|
|
Pub Dt:
|
04/18/2019
| | | | |
|
Title:
|
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17105402
|
Filing Dt:
|
11/25/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/20/2021
| | | | |
|
Title:
|
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF
|
|
|
Assignee
|
|
|
|
|
| 151 OYSTER POINT BOULEVARD, SUITE 400 |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
AMY SHERIDAN
|
| |
151 OYSTER POINT BOULEVARD, SUITE 400
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
Search Results as of:
05/30/2024 03:31 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
